Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells (2019)
Source: Nanomedicine. Unidades: IQ, FCF
Subjects: IMUNOSSUPRESSÃO, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRI, Silvana et al. Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells. Nanomedicine, v. 14, n. 11, p. 1429-1442, 2019Tradução . . Disponível em: https://doi.org/10.2217/nnm-2018-0484. Acesso em: 21 ago. 2024.APA
Sandri, S., Hebeda, C. B., Loiola, R. A., Calgaroto, S., Uchiyama, M. K., Araki, K., et al. (2019). Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells. Nanomedicine, 14( 11), 1429-1442. doi:10.2217/nnm-2018-0484NLM
Sandri S, Hebeda CB, Loiola RA, Calgaroto S, Uchiyama MK, Araki K, Frank LA, Paese K, Guterres SS, Pohlmann AR, Farsky SHP. Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells [Internet]. Nanomedicine. 2019 ; 14( 11): 1429-1442.[citado 2024 ago. 21 ] Available from: https://doi.org/10.2217/nnm-2018-0484Vancouver
Sandri S, Hebeda CB, Loiola RA, Calgaroto S, Uchiyama MK, Araki K, Frank LA, Paese K, Guterres SS, Pohlmann AR, Farsky SHP. Direct effects of poly(ε-caprolactone) lipid-core nanocapsules on human immune cells [Internet]. Nanomedicine. 2019 ; 14( 11): 1429-1442.[citado 2024 ago. 21 ] Available from: https://doi.org/10.2217/nnm-2018-0484